Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Biochem Sues Amersham, Orchid, PerkinElmer, over Labeling Technique

NEW YORK, Oct. 23-Enzo Biochem has filed suit against Amersham, PerkinElmer, Orchid Biosciences and two other companies for breach of contract and patent infringement, the company said today.

 

The suit, filed in the U.S. District Court for the Southern District of New York, alleges that these companies have misused Enzo's nucleotide labeling technologies, methods used in gene sequencing and analysis.

 

Amersham Biosciences, PerkinElmer and Sigma-Aldrich, three of the defendants in the suit, had all signed agreements to distribute Enzo's labeled nucleotide products. Enzo claims that these three distributors were permitted only to distribute these products for research use, but violated their agreements by developing the technology for clinical use, exploiting Enzo's patents without authorization.

 

The other defendants, Orchid and Molecular Probes, are charged with patent infringement.

 

Enzo's corporate headquarters are in New York, NY.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.